UPDATE: Oppenheimer Starts POINT Biopharma Global Inc. (PNT) at Outperform
Tweet Send to a Friend
(Updated - October 10, 2022 4:03 PM EDT)
Oppenheimer analyst Jeff Jones initiates coverage on POINT Biopharma Global Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones initiates coverage on POINT Biopharma Global Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
